Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): All You Need to Know

Metabolic Dysfunction-Associated Steatotic Liver Disease, commonly known as MASLD, is a chronic liver condition caused by excess fat accumulation in liver cells in people with metabolic risk factors. These risk factors include obesity, type 2 diabetes, high blood pressure, abnormal cholesterol levels, and insulin resistance.

MASLD is the updated medical term that replaces Non-Alcoholic Fatty Liver Disease (NAFLD). The change reflects a clearer understanding of the disease cause. It highlights metabolic dysfunction as the primary driver, rather than focusing on alcohol exclusion.

MASLD is now recognized as one of the most common liver diseases worldwide. It affects nearly one in three adults globally, including a growing number of children and adolescents.

According to the World Health Organization(WHO), metabolic diseases are rising rapidly, making MASLD a major public health concern.

Why Was NAFLD Renamed to MASLD?

The term NAFLD was considered outdated and incomplete. It defined the disease by what it was not, rather than what caused it. International liver societies introduced MASLD to bring clarity, accuracy, and inclusivity to diagnosis and care.

Key reasons for the change include:

• Clear identification of metabolic dysfunction as the root cause
• Removal of stigma associated with alcohol-based definitions
• Improved diagnostic precision for clinicians
• Better alignment with cardiovascular and diabetes care pathways

This updated terminology helps patients and doctors focus on metabolic health rather than exclusion criteria.

How Common Is MASLD?

MASLD affects approximately:

• 30 to 35 percent of adults globally
• Over 25 percent of adults in India
• A rapidly increasing number of adolescents with obesity

Urban lifestyles, sedentary habits, processed foods, and rising diabetes rates contribute significantly to this increase.

MASLD is now a leading cause of:

• Chronic liver disease
• Liver cirrhosis
• Liver transplantation

What Causes Metabolic Dysfunction-Associated Steatotic Liver Disease?

MASLD develops when fat accumulation in the liver exceeds 5 percent of liver weight due to metabolic imbalance.

Common causes include:

• Insulin resistance
• Central obesity
• Type 2 diabetes mellitus
• High triglycerides and low HDL cholesterol
• Sedentary lifestyle
• Genetic predisposition

When insulin resistance occurs, the liver stores excess fat instead of processing it efficiently. Over time, this leads to liver inflammation and injury.

What Are the Stages of MASLD?

MASLD progresses gradually. Many patients remain unaware until advanced stages.

Stages of MASLD:

Stage	Description
Simple Steatosis	Fat accumulation without inflammation
MASH	Metabolic dysfunction-associated steatohepatitis with inflammation
Fibrosis	Scar tissue formation
Cirrhosis	Severe scarring and liver dysfunction
Liver Cancer	Increased risk in advanced cirrhosis

While the early stage MASLD is reversible, advanced stage may lead to liver failure.

What Symptoms Should You Watch For?

MASLD is often silent in early stages.

Possible symptoms include:

• Persistent fatigue
• Dull pain or discomfort in the upper right abdomen
• Unexplained weight gain
• Weakness or low energy

Advanced symptoms may include:

• Jaundice (yellowing of eyes and skin)
• Swelling in legs and abdomen
• Easy bruising
• Mental confusion in cirrhosis

Because symptoms appear late, regular screening is essential for at-risk individuals. To learn more about causes, symptoms, and treatment, read our guide on Non-Alcoholic Fatty Liver Disease (NAFLD).

Who Is at High Risk of MASLD?

People with metabolic disorders face the highest risk.

High-risk groups include:

• Individuals with type 2 diabetes
• People with obesity or abdominal fat
• Those with high cholesterol or triglycerides
• Patients with polycystic ovary syndrome
• Individuals with a family history of liver disease

Children with obesity are also increasingly diagnosed with MASLD.

How Is MASLD Diagnosed?

Diagnosis involves a combination of clinical evaluation and tests.

Common diagnostic tools:

• Blood tests (liver enzymes, lipid profile, glucose levels)
• Ultrasound abdomen
• FibroScan (transient elastography)
• MRI-based liver fat quantification
• Liver biopsy in selected cases

Non-invasive tools are now preferred to assess liver fat and fibrosis accurately.

Can MASLD Be Reversed?

Yes. MASLD is reversible in early and intermediate stages with timely intervention.

Evidence-based reversal strategies:

• Weight loss of 7 to 10 percent
• Improved insulin sensitivity
• Regular physical activity
• Dietary modification
• Optimal diabetes and lipid control

Lifestyle changes remain the foundation of MASLD management.

What Is the Best Diet for MASLD?

There is no single diet, but certain patterns show strong benefits.

Recommended dietary principles:

• Mediterranean-style diet
• High intake of vegetables, fruits, and whole grains
• Lean protein sources
• Healthy fats such as olive oil and nuts
• Reduced sugar and refined carbohydrates

Foods to limit:

• Sugary beverages
• Ultra-processed foods
• Saturated and trans fats

How Important Is Exercise in MASLD Management?

Exercise improves liver fat content even without significant weight loss.

Recommended activity:

• At least 150 minutes of moderate aerobic exercise weekly
• Resistance training twice weekly
• Reduced sedentary time

Consistency matters more than intensity.

Are There Medications for MASLD?

Currently, no medication is specifically approved for MASLD.

However, doctors may prescribe:

• Insulin sensitizers
• Lipid-lowering agents
• Vitamin E in selected patients
• Medications for diabetes and obesity

Several drugs are under advanced clinical trials.

How Is MASLD Different From Alcoholic Liver Disease?

MASLD occurs in individuals with minimal or no alcohol intake. The disease is driven by metabolic dysfunction rather than alcohol toxicity.

Both conditions may look similar on imaging, but the underlying cause and management differ.

What Happens If MASLD Is Left Untreated?

Untreated MASLD can progress silently.

Potential complications include:

• Advanced fibrosis
• Liver cirrhosis
• Hepatocellular carcinoma
• Cardiovascular disease
• Reduced life expectancy

Among these complications, Cardiovascular disease remains the leading cause of death in MASLD patients.

A Clear Path Forward for Liver Health

Metabolic Dysfunction-Associated Steatotic Liver Disease is a growing yet preventable health challenge. MASLD is not just a liver disease. It reflects overall metabolic health. Early detection, patient education, and coordinated care between physicians, nutritionists, and hepatologists are essential.

Recognizing the causes, being aware of the risk factors and taking early preventive measures can protect the liver, prevent heart disease, stroke and kidney disease. With proper screening, lifestyle modification, and professional medical advice, the long-term prognosis can be significantly improved.

At the Chennai Liver Foundation, evidence-based practice, education, and compassionate medical expertise continue to play a pivotal role in the management of MASLD and lifelong liver health.

Frequently Asked Questions(FAQs)

Is MASLD the same as fatty liver?

MASLD is a type of fatty liver disease linked specifically to metabolic dysfunction.

Can lean people develop MASLD?

Yes. Lean individuals with insulin resistance or genetic risk can develop MASLD.

Does MASLD always lead to cirrhosis?

No. Many patients remain stable with proper lifestyle management.

Is MASLD reversible without medication?

Yes. Lifestyle modification is the most effective treatment in early stages.

Should people with diabetes be screened for MASLD?

Yes. Regular liver screening is recommended for people with diabetes.